Clinical and Molecular Studies of Malformations

畸形的临床和分子研究

基本信息

项目摘要

The laboratory uses a translational research approach to study human malformations. In the clinical arena, we operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that we are currently studying include Pallister-Hall, Greig cephalopolysyndactyly, McKusick Kaufman, non-syndromic polydactyly, Proteus, Bardet-Biedl, Lenz microphthalmia, and Oculofaciocardiodental syndromes. We use the tools of modern molecular biology to determine the molecular pathogenesis of these disorders. These include positional cloning, microarray expression and microarray CGH analysis, cell and tissue culture studies to assess cell biologic functions and abnormalities of gene products, and the creation and analysis of animal models of human genetic disease (mouse and zebrafish). Using these techniques we have elucidated the etiology of Pallister-Hall, McKusick-Kaufman, Lenz microphthalmia and Oculofaciocardiodental syndromes. In addition, we have demonstrated the functional defect of Pallister-Hall syndrome by comparing the function of the causative gene in that disorder (GLI3) to its Drosophila homologue (cubitus interruptus) and correlating those functions with mutations in over 150 patients. In so doing, we have determined that the mechanism of Pallister Hall syndrome is distinct from that of Greig cephalopolysyndactyly syndrome. We have also clinically redefined the Proteus syndrome, a disorder of mosaic overgrowth with tumor susceptibility. We did this through evaluating a series of 35 patients and an exhaustive survey of all cases reported in the literature. This allowed us to establish new clinical diagnostic criteria for this disorder and delineate two novel disease entities, the hemihyperplasia-multiple lipomatosis syndrome and CLOVE syndrome. In our studies of Lenz microphthalmia syndrome we determined that this disorder is actually an amalgamation of two distinct X-linked diseases and that one form of Lenz is allelic to Oculofaciocardiodental syndrome and that both of these diseases are caused by mutations in the BCOR gene. Finally, we are using animal models to study two disorders, Amish microcephaly syndrome, which we determined to be caused by mutations in the DNC gene, and a phenocopy of Greig cephalopolysyndactyly syndrome. For Amish microcephaly, we have created a mouse knockout model of that disease using transgenic technology and are studying the pathophysiology of that disorder using genetic and biochemical analysis. We are also performing a positional cloning analysis of the Greig cephalopolysyndactyly phenotype in the mouse using a sporadic mutant identified at a large breeding facility. This disorder has now been mapped to a 500 KB interval and candidate genes are being sequenced.
实验室使用转化研究方法来研究人类畸形。在临床领域,我们运行了几种临床研究方案,以评估多效性发育异常的严重程度,畸形谱和自然历史的范围。我们使用包括病史和体格检查的临床评估,包括射线照相,超声和断层扫描以及脑电图,肺功能测试等的成像研究,以表征功能和结构异常。在选定的情况下,如果它们提供临床益处,并可以提高我们对正在研究的疾病的理解,我们还可以进行手术治疗。我们目前正在研究的某些疾病包括Pallister-Hall,Greig Cephalophyndactyly,McKusick Kaufman,非综合性多态度,Proteus,Bardet-Biedl,Lenz Microphtllmia和Oculofaciofaciarofaciarofaciarofaciocararmia和oculofaciocarardiodental consyndromes。 我们使用现代分子生物学的工具来确定这些疾病的分子发病机理。其中包括位置克隆,微阵列表达和微阵列CGH分析,细胞和组织培养研究,以评估基因产物的细胞生物学功能和异常,以及人类遗传疾病(小鼠和斑马鱼)动物模型的创建和分析。 使用这些技术,我们阐明了Pallister-Hall,McKusick-Kaufman,Lenz Microphthalmia和Oculofaciocardiodental综合征的病因。此外,我们通过比较该疾病(GLI3)与其果蝇同源物(Cubitus Intruptus)的功能,证明了Pallister-Hall综合征的功能缺陷,并将这些功能与150多名患者的突变相关联。这样一来,我们确定了Pallister Hall综合征的机理与Greig Cephalopolysyndactyly综合征的机制不同。我们还在临床上重新定义了Proteus综合征,Proteus综合征是一种具有肿瘤敏感性的镶嵌过度生长的疾病。我们通过评估了一系列35名患者和对文献报道的所有病例进行详尽的调查来做到这一点。这使我们能够为这种疾病建立新的临床诊断标准,并描绘了两个新型疾病实体,即半血肿 - 多脂瘤病综合征和丁香综合征。在我们对LENZ微心理综合征的研究中,我们确定这种疾病实际上是两种不同的X连锁疾病的融合性,而Lenz的一种形式是Oculofaciocardiodental综合征的等位基因,并且这两种疾病都是由Bcor Gene中的突变引起的。 最后,我们正在使用动物模型研究两种疾病,即阿米什小头畸形综合征,我们确定是由DNC基因突变引起的,以及Greig Cephalopyndactyly综合征的表观。对于阿米什小头畸形,我们使用转基因技术创建了该疾病的小鼠敲除模型,并正在使用遗传和生化分析研究该疾病的病理生理学。我们还使用在大型育种设施上鉴定出的零星突变体进行了小鼠中Greig头孢菌的表型的位置克隆分析。现在,该疾病已被映射到500 kb的间隔,并且正在测序候选基因。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Leslie Biesecker的其他基金

NHGRI/DIR Cytogenetics and Microscopy Core
NHGRI/DIR 细胞遗传学和显微镜核心
  • 批准号:
    8565588
    8565588
  • 财政年份:
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:
NHGRI/DIR Embryonic Stem Cell and Transgenic Mouse Core
NHGRI/DIR 胚胎干细胞和转基因小鼠核心
  • 批准号:
    8565589
    8565589
  • 财政年份:
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:
ClinSeq
临床测序
  • 批准号:
    7968944
    7968944
  • 财政年份:
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:
ClinSeq - Clinical and Behavioral Aspects
ClinSeq - 临床和行为方面
  • 批准号:
    8750717
    8750717
  • 财政年份:
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:
ClinSeq - Clinical and Behavioral Aspects
ClinSeq - 临床和行为方面
  • 批准号:
    9358526
    9358526
  • 财政年份:
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:
ClinSeq
临床测序
  • 批准号:
    8350014
    8350014
  • 财政年份:
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:
ClinSeq
临床测序
  • 批准号:
    7734927
    7734927
  • 财政年份:
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:
Genomic Ascertainment - Clinical and Behavioral Aspects
基因组确定 - 临床和行为方面
  • 批准号:
    10683830
    10683830
  • 财政年份:
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:
NHGRI/DIR Cytogenetics and Microscopy Core
NHGRI/DIR 细胞遗传学和显微镜核心
  • 批准号:
    8177745
    8177745
  • 财政年份:
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:
Clinical and Molecular Studies of Malformations
畸形的临床和分子研究
  • 批准号:
    8565547
    8565547
  • 财政年份:
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:

相似国自然基金

髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
  • 批准号:
    82372496
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
  • 批准号:
    82300396
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
  • 批准号:
    32370568
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
  • 批准号:
    82360332
  • 批准年份:
    2023
  • 资助金额:
    31.00 万元
  • 项目类别:
    地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
  • 批准号:
    82303057
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Substrate reduction as a novel therapeutic strategy for Glutaric Aciduria Type 1
减少底物作为 1 型戊二酸尿症的新型治疗策略
  • 批准号:
    10396619
    10396619
  • 财政年份:
    2021
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:
Substrate reduction as a novel therapeutic strategy for Glutaric Aciduria Type 1
减少底物作为 1 型戊二酸尿症的新型治疗策略
  • 批准号:
    10216580
    10216580
  • 财政年份:
    2021
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:
Role of troponin T isoforms in nemaline myopathy
肌钙蛋白 T 同工型在线状肌病中的作用
  • 批准号:
    7743295
    7743295
  • 财政年份:
    2002
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:
Role of Troponin T Isoforms in Nemaline Myopathy
肌钙蛋白 T 同工型在线形肌病中的作用
  • 批准号:
    8531650
    8531650
  • 财政年份:
    2002
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别:
Role of troponin T isoforms in nemaline myopathy
肌钙蛋白 T 同工型在线状肌病中的作用
  • 批准号:
    7943867
    7943867
  • 财政年份:
    2002
  • 资助金额:
    $ 161.22万
    $ 161.22万
  • 项目类别: